Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

NCT07490509 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

235

Enrollment

OTHER

Sponsor class

Conditions

Abemaciclib
Abemaciclib-related Diarrhea
Breast Cancer

Interventions

BIOLOGICAL: Blood samples for PK
OTHER: Questionnaire

Sponsor

Poitiers University Hospital